[go: up one dir, main page]

NO20043960L - Anvendelse av en inhibitor eller antagonist mot vevsfaktor - Google Patents

Anvendelse av en inhibitor eller antagonist mot vevsfaktor

Info

Publication number
NO20043960L
NO20043960L NO20043960A NO20043960A NO20043960L NO 20043960 L NO20043960 L NO 20043960L NO 20043960 A NO20043960 A NO 20043960A NO 20043960 A NO20043960 A NO 20043960A NO 20043960 L NO20043960 L NO 20043960L
Authority
NO
Norway
Prior art keywords
inhibitor
tissue factor
against tissue
antagonist against
antagonist
Prior art date
Application number
NO20043960A
Other languages
English (en)
Norwegian (no)
Inventor
Olle Korsgren
Bo Nilsson
Original Assignee
Prophy Med Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0200545A external-priority patent/SE0200545D0/xx
Priority claimed from SE0203540A external-priority patent/SE0203540D0/xx
Application filed by Prophy Med Ab filed Critical Prophy Med Ab
Publication of NO20043960L publication Critical patent/NO20043960L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20043960A 2002-02-22 2004-09-21 Anvendelse av en inhibitor eller antagonist mot vevsfaktor NO20043960L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0200545A SE0200545D0 (sv) 2002-02-22 2002-02-22 Use of an inhibitor or antagonist against tissue factor
SE0203540A SE0203540D0 (sv) 2002-02-21 2002-11-28 Use of an inhibilor or antagonist against lissue factor
PCT/SE2003/000289 WO2003070275A1 (fr) 2002-02-22 2003-02-21 Utilisation d'un inhibiteur ou antagoniste du facteur tissulaire

Publications (1)

Publication Number Publication Date
NO20043960L true NO20043960L (no) 2004-11-10

Family

ID=27759837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043960A NO20043960L (no) 2002-02-22 2004-09-21 Anvendelse av en inhibitor eller antagonist mot vevsfaktor

Country Status (16)

Country Link
US (1) US20050255111A1 (fr)
EP (1) EP1476186A1 (fr)
JP (1) JP2005528343A (fr)
KR (1) KR20050004785A (fr)
CN (1) CN1646162A (fr)
AP (1) AP2004003113A0 (fr)
AU (1) AU2003206571A1 (fr)
CA (1) CA2476832A1 (fr)
CO (1) CO5611170A2 (fr)
IL (1) IL163605A0 (fr)
MX (1) MXPA04008061A (fr)
NO (1) NO20043960L (fr)
NZ (1) NZ535199A (fr)
RU (1) RU2315621C2 (fr)
TN (1) TNSN04160A1 (fr)
WO (1) WO2003070275A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA109633C2 (uk) 2008-12-09 2015-09-25 Антитіло людини проти тканинного фактора
SMT201700547T1 (it) 2010-06-15 2018-01-11 Genmab As Coniugati di farmaco anticorpo umano contro il fattore tissutale
TWI841554B (zh) 2018-03-21 2024-05-11 丹麥商珍美寶股份有限公司 以鉑為主之劑與抗組織因子抗體－藥物共軛物的組合治療癌症之方法
UA130009C2 (uk) 2018-05-07 2025-10-15 Генмаб А/С Спосіб лікування раку за допомогою комбінації антитіла до pd-1 і кон'югата антитіла до тканинного фактора і лікарського засобу
TWI844571B (zh) 2018-10-30 2024-06-11 丹麥商珍美寶股份有限公司 使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法
CN115944738B (zh) * 2022-12-13 2024-06-18 华中科技大学同济医学院附属同济医院 补体c3裂解抑制剂在制备治疗糖尿病心肌病的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506134A (en) * 1990-10-22 1996-04-09 Corvas International, Inc. Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex
ES2169128T3 (es) * 1994-04-13 2002-07-01 Res Corp Technologies Inc Procedimientos para el tratamiento de enfermedades utilizando celulas de sertoli y aloinjertos o xenoinjertos.
DE69632465T2 (de) * 1995-06-07 2005-06-23 Ortho-Mcneil Pharmaceutical, Inc. Cdr-transplantierte antikörper gegen "tissue factor" und verfahren zur deren verwendung
GB9606452D0 (en) * 1996-03-27 1996-06-05 Sandoz Ltd Organic compounds
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
US5986065A (en) * 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US6387366B1 (en) * 1998-12-31 2002-05-14 Alg Company Methods for reducing adverse side effects associated with cellular transplantation
AU784426C (en) * 1999-10-27 2007-02-01 Tanox, Inc. Tissue factor antagonists and methods of use thereof
CA2402596A1 (fr) * 2000-03-16 2001-09-27 Genentech, Inc. Anticorps de facteur anti-tissulaire a pouvoir anticoagulant ameliore
US6579531B2 (en) * 2000-06-16 2003-06-17 Thomas T. Aoki Method for treating heart disease and cardiovascular disease in diabetic and non-diabetic patients

Also Published As

Publication number Publication date
CN1646162A (zh) 2005-07-27
NZ535199A (en) 2006-03-31
KR20050004785A (ko) 2005-01-12
RU2004128238A (ru) 2005-05-20
TNSN04160A1 (en) 2007-03-12
AP2004003113A0 (en) 2004-09-30
IL163605A0 (en) 2005-12-18
MXPA04008061A (es) 2005-06-20
CO5611170A2 (es) 2006-02-28
JP2005528343A (ja) 2005-09-22
WO2003070275A1 (fr) 2003-08-28
CA2476832A1 (fr) 2003-08-28
RU2315621C2 (ru) 2008-01-27
AU2003206571A1 (en) 2003-09-09
US20050255111A1 (en) 2005-11-17
EP1476186A1 (fr) 2004-11-17

Similar Documents

Publication Publication Date Title
CY2013043I1 (el) Ενωσεις 4-οξοκινολινης και χρησιμοποιηση αυτων ως αναστολεις της ενσωματασης του hiv
DE60334140D1 (de) Mehrlagige tissueprodukte
ATE445614T1 (de) Phosphatidylinositol 3-kinase inhibitoren
PL374832A1 (pl) Nowe podstawione benzoimidazolowe postacie dawkowe i sposoby ich stosowania
NO2014008I2 (no) Linagliptin
FR2837508B1 (fr) Mur antibruit
DE60319330D1 (de) Chirurgisches Instrument
DE60301088D1 (de) Chirurgische Kassette
EP1500371A4 (fr) Echographe
DK1487541T3 (da) Anvendelse af IL-18-inhibitorer til behandling og/eller forebyggelse af perifere vaskulære sygdomme
EP1660436A4 (fr) Inhibiteurs de la cathepsine
EP1535609A4 (fr) Inhibiteur de l'activation de nf-kb
FI20031407A0 (fi) Taajuusmuuttajien tai invertterien rinnankäytön ohjaus
JP2006502186A5 (ja) β-グルカンの使用
DE60304985D1 (de) Toiletteneinheit eines Flugzeuges
DE60307540D1 (de) Verteiltenechounterdrückung
DK1393691T3 (da) Kirurgisk konsol
NO20043960L (no) Anvendelse av en inhibitor eller antagonist mot vevsfaktor
SE0200545D0 (sv) Use of an inhibitor or antagonist against tissue factor
SE0203540D0 (sv) Use of an inhibilor or antagonist against lissue factor
DE10393352D2 (de) Skalpell
DE50301665D1 (de) Torblatthandgriff sowie Verwendung desselben
HK1071072A (en) Use of an inhibitor or antagonist against tissue factor
FI20030525A0 (fi) Suuntaajavälineiden suojauskokoonpano
DE60331820D1 (de) Beseitigung von verstopfungen von rohrleitungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application